prgram v.16  

A Mobile Application for Telerehabilitation in Parkinson's Disease  

The purpose of this study is to determine if the 9zest app for Parkinson's disease is feasible, safe, and efficacious when used independently by individuals with Parkinson's disease.

Study Website  

Study Website

A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease  

This is a multicenter randomized, double-blind, placebo-controlled Phase 2 study designed to evaluate the efficacy, safety, and tolerability of two doses of CT1812 compared to placebo in participants diagnosed with early Alzheimer's disease.

Trial 1 3.8

Trial 1 3.8

test trial 2 3.8

test trial 2 3.8

Test Camapign v3.8

Test Campaign v3.8

Check Ref  

Check Ref

check logo

check logo

common trial

common trialcommon trialcommon trialcommon trial